Accelerated fetal growth in early pregnancy and risk of preterm birth: a prospective cohort study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
09 Dec 2020
Historique:
received: 24 06 2020
accepted: 25 11 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 13 5 2021
Statut: epublish

Résumé

Preterm birth (occurring before 37 completed weeks of gestation) affects 15 million infants annually, 7.5% of which die due to related complications. The detection and early diagnosis are therefore paramount in order to prevent the development of prematurity and its consequences. So far, focus has been laid on the association between reduced intrauterine fetal growth during late gestation and prematurity. The aim of the current study was to investigate the association between accelerated fetal growth in early pregnancy and the risk of preterm birth. This prospective cohort study included 69,617 singleton pregnancies without congenital malformations and with available biometric measurements during the first and second trimester. Estimation of fetal growth was based on measurements of biparietal diameter (BPD) at first and second trimester scan. We investigated the association between accelerated fetal growth and preterm birth prior to 37 weeks of gestation. The outcome was further stratified into very preterm birth (before 32 weeks of gestation) or moderate preterm birth (between 32 and 37 weeks of gestation) and medically induced or spontaneous preterm birth and was further explored. The odds of prematurity were increased among fetuses with accelerated BPD growth (> 90th centile) estimated between first and second ultrasound scan, even after adjustment for possible confounders (aOR 1.36; 95% CI 1.20-1.54). The findings remained significant what regards moderate preterm births but not very preterm births. Regarding medically induced preterm birth, the odds were found to be elevated in the group of fetuses with accelerated growth in early pregnancy (aOR 1.34; 95% CI 1.11-1.63). On the contrary, fetuses with delayed fetal growth exhibited lower odds for both overall and spontaneous preterm birth. Fetuses with accelerated BPD growth in early pregnancy, detected by ultrasound examination during the second trimester, exhibited increased odds of being born preterm. The findings of the current study suggest that fetal growth in early pregnancy should be taken into account when assessing the risk for preterm birth.

Sections du résumé

BACKGROUND BACKGROUND
Preterm birth (occurring before 37 completed weeks of gestation) affects 15 million infants annually, 7.5% of which die due to related complications. The detection and early diagnosis are therefore paramount in order to prevent the development of prematurity and its consequences. So far, focus has been laid on the association between reduced intrauterine fetal growth during late gestation and prematurity. The aim of the current study was to investigate the association between accelerated fetal growth in early pregnancy and the risk of preterm birth.
METHODS METHODS
This prospective cohort study included 69,617 singleton pregnancies without congenital malformations and with available biometric measurements during the first and second trimester. Estimation of fetal growth was based on measurements of biparietal diameter (BPD) at first and second trimester scan. We investigated the association between accelerated fetal growth and preterm birth prior to 37 weeks of gestation. The outcome was further stratified into very preterm birth (before 32 weeks of gestation) or moderate preterm birth (between 32 and 37 weeks of gestation) and medically induced or spontaneous preterm birth and was further explored.
RESULTS RESULTS
The odds of prematurity were increased among fetuses with accelerated BPD growth (> 90th centile) estimated between first and second ultrasound scan, even after adjustment for possible confounders (aOR 1.36; 95% CI 1.20-1.54). The findings remained significant what regards moderate preterm births but not very preterm births. Regarding medically induced preterm birth, the odds were found to be elevated in the group of fetuses with accelerated growth in early pregnancy (aOR 1.34; 95% CI 1.11-1.63). On the contrary, fetuses with delayed fetal growth exhibited lower odds for both overall and spontaneous preterm birth.
CONCLUSIONS CONCLUSIONS
Fetuses with accelerated BPD growth in early pregnancy, detected by ultrasound examination during the second trimester, exhibited increased odds of being born preterm. The findings of the current study suggest that fetal growth in early pregnancy should be taken into account when assessing the risk for preterm birth.

Identifiants

pubmed: 33297996
doi: 10.1186/s12884-020-03458-x
pii: 10.1186/s12884-020-03458-x
pmc: PMC7724842
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

764

Subventions

Organisme : Akademiska Sjukhuset
ID : ALF 1040530/2019

Références

JAMA. 2010 Feb 10;303(6):527-34
pubmed: 20145229
Lancet. 2005 Mar 5-11;365(9462):891-900
pubmed: 15752534
Am J Obstet Gynecol. 2006 Jul;195(1):154-61
pubmed: 16813752
Am J Physiol. 1980 Mar;238(3):C81-9
pubmed: 7369350
Clin Perinatol. 2011 Sep;38(3):423-39
pubmed: 21890017
Reprod Health. 2013;10 Suppl 1:S2
pubmed: 24625129
Am J Obstet Gynecol. 2001 Apr;184(5):946-53
pubmed: 11303203
Acta Obstet Gynecol Scand. 2016 Sep;95(9):1034-41
pubmed: 27216473
Ultrasound Obstet Gynecol. 2008 Aug;32(2):147-54
pubmed: 18663771
Am J Perinatol. 2018 Apr;35(5):494-502
pubmed: 29183099
Am J Obstet Gynecol. 2015 Dec;213(6):830.e1-830.e19
pubmed: 26284599
BMJ Open. 2019 Feb 1;9(1):e023004
pubmed: 30782691
BJOG. 2017 Oct;124(11):1708-1716
pubmed: 28236376
BJOG. 2008 Sep;115(10):1273-8
pubmed: 18715413
JAMA. 2016 Jul 26;316(4):410-9
pubmed: 27458946
BJOG. 2017 Jul;124(8):1235-1244
pubmed: 27770495
J Pediatr. 2009 Feb;154(2):169-76
pubmed: 19081113
Acta Obstet Gynecol Scand. 2019 Jan;98(1):106-116
pubmed: 30169899
Am J Hum Biol. 2009 Mar-Apr;21(2):141-50
pubmed: 18988282
Reprod Sci. 2015 Dec;22(12):1603-11
pubmed: 26507870
J Clin Endocrinol Metab. 2005 Jan;90(1):237-46
pubmed: 15494465
Obstet Gynecol Surv. 2017 Oct;72(10):603-609
pubmed: 29059452
BMJ Open. 2018 Apr 5;8(4):e020449
pubmed: 29622576
Am J Obstet Gynecol. 1996 Mar;174(3):843-9
pubmed: 8633654
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Acta Obstet Gynecol Scand. 2017 Oct;96(10):1261-1268
pubmed: 28683173
Am J Epidemiol. 2016 Jul 15;184(2):110-9
pubmed: 27370790
Int J Epidemiol. 2014 Aug;43(4):1140-53
pubmed: 24603318
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
Biomed Res Int. 2017;2017:1953076
pubmed: 28421190
Lancet. 2013 Jan 19;381(9862):223-34
pubmed: 23158883

Auteurs

Evangelia Elenis (E)

Department of Children's and Women's Health, Uppsala University, Uppsala University Hospital, SE-751 85, Uppsala, Sweden. evangelia.elenis@kbh.uu.se.

Anna-Karin Wikström (AK)

Department of Children's and Women's Health, Uppsala University, Uppsala University Hospital, SE-751 85, Uppsala, Sweden.

Marija Simic (M)

Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska University Hospital and Institutet, Stockholm, SE-17176, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH